114 related articles for article (PubMed ID: 24593003)
1. Topical administration of dual siRNAs using fusogenic lipid nanoparticles for treating psoriatic-like plaques.
Marepally S; Boakye CH; Patel AR; Godugu C; Doddapaneni R; Desai PR; Singh M
Nanomedicine (Lond); 2014 Jul; 9(14):2157-74. PubMed ID: 24593003
[TBL] [Abstract][Full Text] [Related]
2. Novel amphiphilic lipid augments the co-delivery of erlotinib and IL36 siRNA into the skin for psoriasis treatment.
Boakye CHA; Patel K; Doddapaneni R; Bagde A; Marepally S; Singh M
J Control Release; 2017 Jan; 246():120-132. PubMed ID: 27170227
[TBL] [Abstract][Full Text] [Related]
3. Topical delivery of anti-TNFα siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo.
Desai PR; Marepally S; Patel AR; Voshavar C; Chaudhuri A; Singh M
J Control Release; 2013 Aug; 170(1):51-63. PubMed ID: 23643662
[TBL] [Abstract][Full Text] [Related]
4. Using siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation in psoriasis.
Nemati H; Ghahramani MH; Faridi-Majidi R; Izadi B; Bahrami G; Madani SH; Tavoosidana G
J Control Release; 2017 Dec; 268():259-268. PubMed ID: 29074408
[TBL] [Abstract][Full Text] [Related]
5. Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis.
Viegas JSR; Praça FG; Caron AL; Suzuki I; Silvestrini AVP; Medina WSG; Del Ciampo JO; Kravicz M; Bentley MVLB
Drug Deliv Transl Res; 2020 Jun; 10(3):646-660. PubMed ID: 32060883
[TBL] [Abstract][Full Text] [Related]
6. Dendrimer as a new potential carrier for topical delivery of siRNA: A comparative study of dendriplex vs. lipoplex for delivery of TNF-α siRNA.
Pandi P; Jain A; Kommineni N; Ionov M; Bryszewska M; Khan W
Int J Pharm; 2018 Oct; 550(1-2):240-250. PubMed ID: 30165098
[TBL] [Abstract][Full Text] [Related]
7. TNFα siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy.
Suzuki IL; de Araujo MM; Bagnato VS; Bentley MVLB
J Control Release; 2021 Oct; 338():316-329. PubMed ID: 34437914
[TBL] [Abstract][Full Text] [Related]
8. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
[TBL] [Abstract][Full Text] [Related]
9. Anti-psoriatic potential of Solanum xanthocarpum stem in Imiquimod-induced psoriatic mice model.
Parmar KM; Itankar PR; Joshi A; Prasad SK
J Ethnopharmacol; 2017 Feb; 198():158-166. PubMed ID: 28052238
[TBL] [Abstract][Full Text] [Related]
10. Laser-assisted nanocarrier delivery to achieve cutaneous siRNA targeting for attenuating psoriasiform dermatitis.
Lee WR; Chou WL; Lin ZC; Sung CT; Lin CY; Fang JY
J Control Release; 2022 Jul; 347():590-606. PubMed ID: 35623494
[TBL] [Abstract][Full Text] [Related]
11. Multi-component clobetasol-loaded monolithic lipid-polymer hybrid nanoparticles ameliorate imiquimod-induced psoriasis-like skin inflammation in Swiss albino mice.
Pukale SS; Sharma S; Dalela M; Singh AK; Mohanty S; Mittal A; Chitkara D
Acta Biomater; 2020 Oct; 115():393-409. PubMed ID: 32846238
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus and curcumin co-loaded liposphere gel: Synergistic combination towards management of psoriasis.
Jain A; Doppalapudi S; Domb AJ; Khan W
J Control Release; 2016 Dec; 243():132-145. PubMed ID: 27725194
[TBL] [Abstract][Full Text] [Related]
13. Targeted silencing of DEFB4 in a bioengineered skin-humanized mouse model for psoriasis: development of siRNA SECosome-based novel therapies.
Bracke S; Carretero M; Guerrero-Aspizua S; Desmet E; Illera N; Navarro M; Lambert J; Del Rio M
Exp Dermatol; 2014 Mar; 23(3):199-201. PubMed ID: 24428418
[TBL] [Abstract][Full Text] [Related]
14. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
Fang JY; Fang CL; Liu CH; Su YH
Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
[TBL] [Abstract][Full Text] [Related]
15. Self-assembly of stable monomolecular nucleic acid lipid particles with a size of 30 nm.
Rudorf S; Rädler JO
J Am Chem Soc; 2012 Jul; 134(28):11652-8. PubMed ID: 22694262
[TBL] [Abstract][Full Text] [Related]
16. Topical delivery of interferon alpha by biphasic vesicles: evidence for a novel nanopathway across the stratum corneum.
Foldvari M; Badea I; Wettig S; Baboolal D; Kumar P; Creagh AL; Haynes CA
Mol Pharm; 2010 Jun; 7(3):751-62. PubMed ID: 20349952
[TBL] [Abstract][Full Text] [Related]
17. Nanocrystal-based gel of apremilast ameliorates imiquimod-induced psoriasis by suppressing inflammatory responses.
Parmar PK; Sharma N; Wasil Kabeer S; Rohit A; Bansal AK
Int J Pharm; 2022 Jun; 622():121873. PubMed ID: 35640806
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle-Assisted Transcutaneous Delivery of a Signal Transducer and Activator of Transcription 3-Inhibiting Peptide Ameliorates Psoriasis-like Skin Inflammation.
Kim JY; Ahn J; Kim J; Choi M; Jeon H; Choe K; Lee DY; Kim P; Jon S
ACS Nano; 2018 Jul; 12(7):6904-6916. PubMed ID: 29949348
[TBL] [Abstract][Full Text] [Related]
19. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
[TBL] [Abstract][Full Text] [Related]
20. Liposphere mediated topical delivery of thymoquinone in the treatment of psoriasis.
Jain A; Pooladanda V; Bulbake U; Doppalapudi S; Rafeeqi TA; Godugu C; Khan W
Nanomedicine; 2017 Oct; 13(7):2251-2262. PubMed ID: 28647592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
